Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as an ophthalmic solution for ocular use. It reduces inflammation and pain in a variety of eye conditions, particularly after surgery or in inflammatory eye disease. Maxidex is administered directly to the eye as directed by a qualified eye‑care professional.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxidex is a corticosteroid eye drop used to manage inflammatory conditions of the eye. It acts locally to control swelling and discomfort. - Post‑operative ocular inflammation: reduces swelling and pain after eye surgery. - Anterior uveitis: controls intra‑ocular inflammation and prevents tissue damage. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergic reactions.

Adverse reactions may occur with ocular dexamethasone use. Patients should be monitored for both frequent and less common events.

Common Side Effects: - Transient eye irritation or burning sensation. - Blurred vision. - Increased intra‑ocular pressure. - Conjunctival hyperemia. - Tearing or watery eyes. - Foreign body sensation.

Serious or Rare Side Effects: - Secondary glaucoma. - Cataract formation with prolonged use. - Ocular infection (bacterial, fungal, or viral). - Delayed wound healing after surgery. - Severe hypersensitivity or allergic reaction. - Corneal ulceration.

Before prescribing Maxidex, clinicians should consider several safety measures. - Intra‑ocular pressure monitoring: check pressure before and during therapy. - Viral eye infections: avoid use in active herpes simplex or varicella‑zoster infections. - Diabetes mellitus: monitor blood glucose as steroids may affect control. - Cataract risk: limit duration in patients with pre‑existing lens opacity. - Contact lens wear: advise removal during treatment to reduce irritation. - Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Dexamethasone eye drops can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: may increase systemic glucocorticoid effects. - Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of corneal melting. - Antiviral eye medications: potential reduction in antiviral efficacy.

Moderate Interactions (Monitor Closely): - Antifungal eye drops: monitor for reduced antifungal activity. - Beta‑blocker eye drops: possible additive intra‑ocular pressure effects. - CYP3A4 inducers (e.g., rifampin): may decrease local steroid concentration. - Anticholinergic eye drops: watch for delayed pupil dilation. - Immunosuppressants: increased risk of infection.